Life Sciences

Equiva will integrate Belong.Life's offerings into its digital platform to give patients and caregivers access to AI health mentors.   

Amprion CEO Russ Lebovitz says proteins in the brain can misfold and form particles that spread from cell to cell, triggering neurodegenerative diseases. A test can identify these proteins, allowing for early diagnosis before symptoms appear.

The alliance will combine HeartBeam's ECG device with AccurKardia's monitoring software.  

Lilly accuses four compounders of selling unauthorized versions of the pharma giant's diabetes and weight-loss drugs.

The company will use the funds to expand access to its AI-powered offering and improve operational efficiencies.   

Yosi Health will join Elation's marketplace that connects primary care practices with technology platforms.  

The alliance combines ConcertAI's data platform with Bayer's scientific and AI expertise.

The company will use the funds to invest in companies that focus on the physical, mental, spiritual and social needs of senior adults.   

Hippocratic AI's generative AI healthcare agents will be deployed across United Arab Emirates-based Burjeel Holding's healthcare network.   

The partnership will focus on building AI tools that accelerate heart disease and cancer detection with the aim of reducing diagnostic turnaround times.